This podcast tells the story of how a community-based COVID-19 research study was formed from a partnership between Oracle Health Sciences, Javara Research and Wake Forest Baptist Health, with the end goal of using regional infection patterns to understand the virus and develop strategies to contain it.

Kathy Vandebelt of Oracle sat down to talk about the partnership enhanced Oracle's Therapeutic Learning System, which was set up to track how physicians were treating individuals infected with the virus and making the information available for others to learn from, for a real-world surveillance study. The collaboration resulted in the addition of a new component for the platform, the Patient Monitoring System, which aided in collecting daily information across a large population of participants and offering them the potential to participate in regular testing. That technology is being used for multiple studies on local, regional, national and now global levels.

In the conversation, Ms Vandebelt also discusses the unexpected collaborations that emerged across the research spectrum as a result of the pandemic, how the Oracle team adapted their technology to keep pace with an evolving on-the-ground situation, and how clinical operations might benefit from adopting more decentralized measures, ultimately giving patients more choices.

Guest:

Kathy Vandebelt is Global Head of Clinical Innovation for Oracle Health Sciences, where she uses the power of technology to introduce new experiences and expectations to make the clinical research ecosystem better for patients, healthcare providers, sponsors and regulators.

For more information about Oracle's COVID-19 response, visit Oracle.com. For more information about PharmaTalk Radio podcasts, go to theconferenceforum.org.

How a Covid-19 Research Study was Formed with Oracle, Javara and Wake Forest

Share

Embed